Stephen Scelsa
Co-Founder and Director, Mount Sinai ALS Center · Icahn School of Medicine at Mount Sinai
Credentials: · · · ·
History
- Present
Mount Sinai ALS Center · Icahn School of Medicine at Mount Sinai
- 1994–1995
Clinical Neurophysiology
- 1988–1992
Neurology
Research
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine · 2020 · 415 citations
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Neurology · 2008 · 200 citations
COVID-19-associated Guillain-Barré syndrome: The early pandemic experience
Review · Muscle & Nerve · 2020 · 194 citations
12 papers · 6 as a resident
10 papers
8 papers
8 papers
8 papers
8 papers
7 papers
- DH
7 papers
